Search details
1.
Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance.
J Urol
; 210(1): 38-45, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37042807
2.
Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment.
J Urol
; 209(1): 49-57, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36129376
3.
Renaming Grade Group 1 Prostate "Cancer" From a Pathology Perspective: A Call for Multidisciplinary Discussion.
Adv Anat Pathol
; 2023 Apr 17.
Article
in English
| MEDLINE | ID: mdl-37072903
4.
Hematuria following Post-Prostatectomy Radiotherapy: Incidence Increases with Long-Term Followup.
J Urol
; 207(6): 1236-1245, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35050703
5.
Should Grade Group 1 (GG1) be called cancer?
World J Urol
; 40(1): 15-19, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33432506
6.
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
World J Urol
; 40(6): 1505-1512, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35279732
7.
Pathological characteristics of the large renal mass: potential implication for clinical role of renal biopsy.
Can J Urol
; 28(2): 10620-10624, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33872561
8.
Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.
J Urol
; 202(2): 272-281, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31059667
9.
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.
J Urol
; 202(5): 952-958, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31144591
10.
Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study.
J Magn Reson Imaging
; 49(5): 1374-1380, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30291653
11.
Lymph node count impacts survival following post-chemotherapy retroperitoneal lymphadenectomy for non-seminomatous testicular cancer: a population-based analysis.
BJU Int
; 124(5): 792-800, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31054211
12.
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Future Oncol
; 15(15): 1683-1695, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30968729
13.
A novel transcriptional network for the androgen receptor in human epididymis epithelial cells.
Mol Hum Reprod
; 24(9): 433-443, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-30016502
14.
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.
J Urol
; 199(6): 1510-1517, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29288121
15.
Novel focal therapy treatment options for prostate cancer.
Curr Opin Urol
; 28(2): 178-183, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29232270
16.
Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Curr Opin Urol
; 28(5): 461-468, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29979235
17.
Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database.
Cancer
; 123(2): 245-252, 2017 01 01.
Article
in English
| MEDLINE | ID: mdl-27626903
18.
Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
J Urol
; 198(5): 1027-1032, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28551443
19.
Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
J Urol
; 207(2): 262-264, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34775795
20.
Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer.
J Urol
; 197(3 Pt 1): 684-689, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27663460